Finance

Beta
Lists
LFST:NASDAQ
Lifestance Health Group Inc
$10.28
+4.05%
(+0.40) 1D
$10.28
0.00% (0.00)
After hours
Closed: Jun 26, 4:00:02 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for LFST...
Open
$9.86
High
$10.30
Low
$9.80
Mkt. cap
3.99B
Avg. vol.
3.18M
Volume
14.42M
P/E ratio
178.32
52-wk high
$10.30
52-wk low
$3.74
EPS
$0.06
Beta
1.19
Shares outstanding
387.83M
No. of employees
8K
Open
$9.86
High
$10.30
Low
$9.80
Mkt. cap
3.99B
Avg. vol.
3.18M
Volume
14.42M
P/E ratio
178.32
52-wk high
$10.30
52-wk low
$3.74
EPS
$0.06
Beta
1.19
Shares outstanding
387.83M
No. of employees
8K
News stories
From sources across the web
Profile
Lifestance Health is an American outpatient behavioral health services provider. They provide their services in person and via tele-health. Their services include therapy, psychiatry, TMS, and ketamine therapies. They have landed in lawsuits multiple times over labor violations, leaking of customer information, and misleading investors. Wikipedia
About Lifestance Health Group Inc
CEO-
Employees8.35K
Founded2015
HeadquartersScottsdale, Arizona, United States
SectorHealth care provider
Analyst ratings
Based on 9 analysts giving stock ratings to LFST in the past 3 months
Strong buy
Buy
7
Hold
2
Sell
0
12-month forecast
Based on 9 Wall Street analysts offering 12 month price targets for LFST in the last 3 months.
Highest
Current $10.28
$13.00 (+26.46%)
Average
$10.50 (+2.14%)
Lowest
$9.00 (-12.45%)
Analyst
Recommendation
Action
Price target
Projected
Date
Ryan Daniels
William Blair
Buy
Maintained
-
-
06/10/2026
Scott Fidel
Goldman Sachs
Hold
Initiated
$9.00
-12.5%
06/05/2026
Lisa Gill
J.P. Morgan
Hold
Maintained
$9.00
-12.5%
05/18/2026
Peter Warendorf
Barclays
Buy
Reiterated
$9.00
-12.5%
05/12/2026
Kevin Caliendo
UBS
Buy
Maintained
$13.00
+26.5%
05/08/2026
David Larsen
BTIG
Buy
Maintained
$12.00
+16.7%
05/08/2026
Richard Close
Canaccord Genuity
Buy
Reiterated
$11.00
+7%
05/08/2026
Sean Dodge
BMO Capital
Buy
Reiterated
$11.00
+7%
05/08/2026
Craig Hettenbach
Morgan Stanley
Buy
Maintained
$10.00
-2.7%
05/07/2026
Steve Dechert
KeyBanc
Buy
Maintained
$9.00
-12.5%
02/26/2026
Last report
May 7, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
$0.07 / $0.06
+10.42%beat
Revenue / Est. (USD)
403.48M / 386.12M
+4.50%beat
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
345.31M
363.81M
382.20M
403.48M
Cost of goods sold
236.88M
247.23M
255.90M
267.54M
Cost of revenue
236.88M
247.23M
255.90M
267.54M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
97.38M
95.69M
94.74M
100.24M
Operating expense
111.38M
109.25M
108.18M
113.56M
Total operating expenses
348.26M
356.48M
364.08M
381.11M
Operating income
-2.95M
7.33M
18.12M
22.37M
Other non operating income
-92.00K
-24.00K
-6.00K
-182.00K
EBT including unusual items
-5.94M
4.57M
15.20M
19.76M
EBT excluding unusual items
-5.94M
4.50M
15.24M
20.40M
Income tax expense
-2.15M
3.50M
3.54M
5.52M
Effective tax rate
36.20%
76.44%
23.25%
27.92%
Other operating expenses
-
-
-
-
Net income
-3.79M
1.08M
11.67M
14.24M
Net profit margin
-1.10%
0.30%
3.05%
3.53%
Earnings per share
0.03
0.01
0.09
0.07
Interest and investment income
-
-
-
-
Interest expense
-2.90M
-2.81M
-2.88M
-1.79M
Net interest expenses
-2.90M
-2.81M
-2.88M
-1.79M
Depreciation and amortization charges
14.01M
13.56M
13.43M
13.32M
EBITDA
11.06M
20.89M
31.55M
35.69M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

What's on your mind?
Give me an overview of LFST
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more